SS
MIRM icon

SBI Securities’s Mirum Pharmaceuticals MIRM Stock Holding History

SBI Securities’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85K Buy
+20
New +$1.88K ﹤0.01% 2448
2025
Q4 		– Sell
-150
Closed -$11K – 4146
2025
Q3 		$11K Buy
150
+121
+417% +$7.69K ﹤0.01% 1731
2025
Q2 		$1.48K Buy
+29
New +$1.29K ﹤0.01% 2518

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SBI Securities's MIRM Position: Q1 2026 in Review

SBI Securities opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2026: 20 shares worth $1.85K. The stake represents ﹤0.01% of the portfolio and ranks #2448 among its holdings. This is a return to the name: SBI Securities previously reported a position in MIRM as recently as Q3 2025.

SBI Securities first reported a position in MIRM in Q2 2025 and has held it in 3 quarters since. The position peaked at $11K in Q3 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • SBI Securities held 20 shares of Mirum Pharmaceuticals worth $1.85K as of Q1 2026.
  • Mirum Pharmaceuticals was a new SBI Securities position in Q1 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2448 holding.
  • SBI Securities first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • SBI Securities's Mirum Pharmaceuticals position peaked at $11K in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.